Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Lola Morgan, M.D. | UT Health San Antonio

Contact

210-450-9700

morganl3@uthscsa.edu

Departments & Divisions

Research

Research profile

Clinical

Provider profile

Lola C Morgan, M.D.

Professor

Dr. Morgan works at UT Health San Antonio and is devoted to caring for people with epilepsy.  Her clinics are based at the MARC and University Hospital as well as performing volunteer work as an attending to the Epilepsy Foundation clinics here in Bexar and Uvalde Counties.  Dr. Morgan provides comprehensive management in treating epilepsy with medications, device and surgical options.  As part of this work, she is the Medical Director of the Neurodiagnostic Center based at University Hospital with a passion for quality and safety that is reflected in our care.  Additionally, Dr. Morgan serves as the Co-Director of the South Texas Comprehensive Epilepsy Center and guide the development and goals of our program.  Part of her research work has been based in the inpatient setting, serving as site principal investigator on multiple clinical trials dedicated to improving care for status epilepticus.  She is active in mentoring the future generation of neurologists and epileptologists and has engaged a wide range of mentees from different levels including neurophysiology fellows, neurology residents, engineering and medical students.  The overarching goal of her focus is dedicated to the advancement of the field of epilepsy and providing excellent epilepsy care.  

  • Professional Background

    Education

    • 2000 - MD - Stritch School of Medicine, Loyola University of Chicago
    • 1991 - BFA - cello (cum laude) - College Conservatory of Music, University of Cincinnati

    Training

    • 2005 - Clinical Fellowship - Clinical Neurophysiology EEG/Epilepsy - University of California San Diego
    • 2004 - Residency - Adult. Neurology - University of California Los Angeles
    • 2001 - Internship - Preliminary Medicine - Maricopa Medical Center

    Highlights

    11/2019 Bexar County Medical Society Women in Medicine Leadership Award
    12/2017 Fellow of the American Epilepsy Society: Designated FAES as recognition for service to the AES
    03/2017 ESETT Recognition: "The Pablo Picasso Award" for most creative community consultation and public disclosure of the NIH funded multicenter ESETT trial

    Appointments

    • 09/2020 - Professor - UT Health San Antonio, Neurology, San Antonio
    • 9/2014-08/2020 - Associate Professor / Clinical - UT Health San Antonio, Neurology, San Antonio
    • 7/2010-06/2012 - Attending - Baptist St. Luke`sSan Antonio
    • 1/2009 - Medical Director, Neurodiagnostic Center and Epilepsy Monitoring Unit - University Health SystemSan Antonio
    • 8/2007 - Attending Physician - UT Health San Antonio PhysiciansSan Antonio
    • 8/2007 - Attending Physician - University Health SystemSan Antonio

  • Instruction & Training

    • 08/2010-09/2019, Clinical Neurology Abnormal Examination, UT Health San Antonio
    • 01/2010 - 09/2019, Epilepsy Monitoring Unit Nurse Education Series, University Hospital
    • 11/2007 - 09/2019, Neurology Board Review, UT Health San Antonio
    • 08/2007 - 09/2019, Neurophysiology Fellowship, UT Health San Antonio

  • Research & Grants

    Research profile

    Grants

    Period: 01/2018 - 12/2018
    Funding Agency: Sunovion
    Title: STAR Study: to evaluate the effectriveness of ESL administered once daily as the first adjunctive therapy to levetiracetam or lamotriine or as laster adjunctive therapy in subjects with POS over a 24 week maintenance period
    Role: Principal Investigator

    Period: 01/2016 - 07/2018
    Title: Established Status Epilepticus Treatment Trial A multicenter, randomized, blinded, comparative effectiveness study of fosphenytoin, valproic acid, or levetiracetam in the emergency department treatment of patients with benzodiazepine‐refractory sta
    Role: Co-Investigator

    Period: 01/2015 - 01/2018
    Title: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study To Evaluate The Efficacy And Safety of Lacosamide As Adjunctive Therapy For Uncontrolled Primary Generalized Tonic-Clonic Seizures In Subjects With Idiopathic Generalized E
    Role: Co-Investigator

    Period: 01/2015 - Present
    Title: A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Sage-547 Injection In The Treatment Of Subjects With Super-Refractory Status Epilepticus
    Role: Co-Principal Investigator

    Period: 01/2015 - Present
    Title: An open-label, multicenter extension study to evaluate the long-term safety and efficacy of lacosamide as adjunctive therapy for uncontrolled primary generalized tonic-clonic seizures in subjects with idiopathic generalized epilepsy (EP0012)
    Role: Co-Investigator

    Period: / - Present
    Title: ESETT (Established Status Epilepticus Treatment Trial) :A Multicenter, Randomized, Blinded, Comparative Effectiveness Study of Fosphenytoin, Valproic Acid, or Levetiracetam in the Emergency Department Treatment of Patients With Benzodiazepine-refractory
    Role: Co-Investigator

  • Service

    Department

    Co-Medical Director of the South Texas Comprehensive Epilepsy Center (2013-present)
    Director, Neurophysiology Fellowship (2012-2013)
    Medical Director, Neurodiagnostic Center University Hospital (2009-present)

    School

    Medical School Admissions Committee
    Neurology Residenty Committee
    Neurophysiology Fellowship Committee

    Institutional

    Medical Director, Clinical Management Team, University Hospital
     

    Community

    Course Director, "Seizures and Epilepsy: An Update for People with Epilepsy or Seizure Disorders and Their Caregivers"
    Epilepsy Foundation Central & South Texas

     

  • Publications

      Abstract

      Morgan LC, Cardenas, Damon P, Halford, Jonathan J., Whitmire, Luke E., Lie OV, Jetter, Gina M, Cavazos JE. Automated Processing of Single-Channel Surface Electromyography From Generalized Tonic–Clonic Seizures to Inform Semiology 2019 Jul. (Journal of Clinical Neurophysiology)

      Eslami, V, Morgan LC, Emamzadehfard, S, Hundal, A, Suchita I, Szabo CA. "Characteristics of Interventional Epilepsy Clinical Trials During the Last Decade " American Academy of Neurology; 2019 Apr. (Neurology; vol. 92, no. 15)

      Suchita IA, Rashid S, Morgan LC, Karkar KM, Lie OV, Leary LD, Adhikari I, Szabo CA.. Electroclinical and historical features related to response to AEDs in juvenile myoclonic epilepsy. 2017 Dec. (Abstract No 3.197, American Epilepsy Society Annual Meeting, www.aesnet.org)

      Jonathan J. Halford, Michael R. Sperling, Dileep R. Nair, Dennis J.Dlugos, William OTatum, Jay Harvey, Jacqueline A. French, John R. Pollard, Edward Faught, Katherine H. Noe, Thomas R. Henry, Gina M, Jetter, Lie O, Morgan L, Michael R. Girouard, Damon P.Cardenas, Luke E. Whitmire, Cavazos J. Detection of generalized tonic–clonic seizures using 2017 Nov. p. 1861-1869. (Epilepsia; vol. 58, no. 11)

       

      Journal Article

      Cardenas, DP, Halford, JJ, Whitmire, LE, Morgan LC, Lie OV, Jetter, GM, Cavazos JE. Automated Processing of Single-Channel Surface Electromyography from Generalized Tonic-Clonic Seizures to Inform Semiology Journal of Clinical Neurophysiology 2020 Jan;37(1):56-61

  • Clinical

    Provider profile

    Board Certifications

    • 2013 - American Board of P&Neurology in Epilepsy
    • 2007 - American Board of P&N/Clinical Neurophysiology
    • 2006 - American Board of P&N/Neurology